PPARG and metabolic dysfunction-associated steatotic liver disease: Other studies have reported a positive correlation between increased PPARγ expression and the development of hepatosteatosis and accumulation of hepatic triglycerides in murine models of nonalcoholic fatty liver disease [31–33].